Patten & Patten Inc. TN Trims Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Patten & Patten Inc. TN lessened its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 7.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,970 shares of the pharmacy operator’s stock after selling 3,244 shares during the period. Patten & Patten Inc. TN’s holdings in Walgreens Boots Alliance were worth $1,070,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. EverSource Wealth Advisors LLC grew its stake in Walgreens Boots Alliance by 308.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 845 shares in the last quarter. FinTrust Capital Advisors LLC lifted its holdings in shares of Walgreens Boots Alliance by 2,314.5% in the 3rd quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,273 shares during the period. Tyler Stone Wealth Management grew its position in shares of Walgreens Boots Alliance by 1,280.0% during the 3rd quarter. Tyler Stone Wealth Management now owns 1,380 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 1,280 shares in the last quarter. Milestone Investment Advisors LLC bought a new position in Walgreens Boots Alliance during the 1st quarter worth about $31,000. Finally, Planned Solutions Inc. purchased a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth approximately $34,000. Institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Barclays initiated coverage on shares of Walgreens Boots Alliance in a report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price objective on the stock. Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. HSBC reaffirmed a “reduce” rating and issued a $20.00 price target (down from $27.00) on shares of Walgreens Boots Alliance in a report on Tuesday, February 20th. Raymond James reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Finally, TheStreet raised Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $24.92.

Get Our Latest Stock Analysis on WBA

Walgreens Boots Alliance Trading Down 4.2 %

Shares of WBA stock opened at $18.72 on Wednesday. The stock has a market cap of $16.14 billion, a P/E ratio of -2.67, a P/E/G ratio of 1.20 and a beta of 0.73. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance, Inc. has a fifty-two week low of $18.67 and a fifty-two week high of $36.58. The business has a fifty day simple moving average of $21.65 and a 200-day simple moving average of $22.26.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.38. The business had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business’s revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.16 earnings per share. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 3.24 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction on Tuesday, April 2nd. The stock was bought at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Walgreens Boots Alliance news, Director Valerie B. Jarrett acquired 4,456 shares of the company’s stock in a transaction on Monday, January 29th. The shares were bought at an average cost of $22.44 per share, for a total transaction of $99,992.64. Following the acquisition, the director now directly owns 4,456 shares of the company’s stock, valued at $99,992.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, April 2nd. The shares were acquired at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 20,456 shares of company stock valued at $458,473. 17.40% of the stock is currently owned by corporate insiders.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Recommended Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.